Drug Delivery Devices Industry Research Report 2024
Summary
Drug delivery devices are used to delivery drug to the specific part of body or cure some disease. With the help of drug delivery devices, drug can efficiently reach the target and be in a controlled manner. Generally, there are several of drug delivery devices corresponding to the medicine taken ways, such as syringe, spray bottle and implantable drug delivery devices etc.
According to APO Research, The global Drug Delivery Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Drug Delivery Devices is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Drug Delivery Devices is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Drug Delivery Devices is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Drug Delivery Devices include Cipla, Baxter International, Nipro Corporation, Roche, Boehringer Ingelheim, Allergan, 3M, BD and Catalent, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drug Delivery Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Delivery Devices.
The Drug Delivery Devices market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Delivery Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Delivery Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drug Delivery Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Delivery Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Drug Delivery Devices companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Drug delivery devices are used to delivery drug to the specific part of body or cure some disease. With the help of drug delivery devices, drug can efficiently reach the target and be in a controlled manner. Generally, there are several of drug delivery devices corresponding to the medicine taken ways, such as syringe, spray bottle and implantable drug delivery devices etc.
According to APO Research, The global Drug Delivery Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Drug Delivery Devices is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Drug Delivery Devices is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Drug Delivery Devices is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Drug Delivery Devices include Cipla, Baxter International, Nipro Corporation, Roche, Boehringer Ingelheim, Allergan, 3M, BD and Catalent, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drug Delivery Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Delivery Devices.
The Drug Delivery Devices market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Delivery Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Cipla
- Baxter International
- Nipro Corporation
- Roche
- Boehringer Ingelheim
- Allergan
- 3M
- BD
- Catalent
- Valeant Pharmaceuticals
- Bayer AG
- Chiesi
- Phillips-Medisize
- Johnson & Johnson
- Shandong Weigao
- Pfizer
- B.Braun
- Novartis AG
- Zhengkang
- Gerresheimer
- COVIDIEN Medtronic
- Schott forma vitrum
- Alkermes
- Skyepharma
- Injection Type
- Mucosal Type
- Implanted Type
- Others Type
- Pharmaceutical Companies
- Hospitals
- Clinics
- Other
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Delivery Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drug Delivery Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Delivery Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Drug Delivery Devices companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Drug Delivery Devices by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
2.2.2 Injection Type
2.2.3 Mucosal Type
2.2.4 Implanted Type
2.2.5 Others Type
2.3 Drug Delivery Devices by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 Pharmaceutical Companies
2.3.3 Hospitals
2.3.4 Clinics
2.3.5 Other
2.4 Assumptions and Limitations
3 DRUG DELIVERY DEVICES BREAKDOWN DATA BY TYPE
3.1 Global Drug Delivery Devices Historic Market Size by Type (2019-2024)
3.2 Global Drug Delivery Devices Forecasted Market Size by Type (2025-2030)
4 DRUG DELIVERY DEVICES BREAKDOWN DATA BY APPLICATION
4.1 Global Drug Delivery Devices Historic Market Size by Application (2019-2024)
4.2 Global Drug Delivery Devices Forecasted Market Size by Application (2019-2024)
5 GLOBAL GROWTH TRENDS
5.1 Global Drug Delivery Devices Market Perspective (2019-2030)
5.2 Global Drug Delivery Devices Growth Trends by Region
5.2.1 Global Drug Delivery Devices Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Drug Delivery Devices Historic Market Size by Region (2019-2024)
5.2.3 Drug Delivery Devices Forecasted Market Size by Region (2025-2030)
5.3 Drug Delivery Devices Market Dynamics
5.3.1 Drug Delivery Devices Industry Trends
5.3.2 Drug Delivery Devices Market Drivers
5.3.3 Drug Delivery Devices Market Challenges
5.3.4 Drug Delivery Devices Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Drug Delivery Devices Players by Revenue
6.1.1 Global Top Drug Delivery Devices Players by Revenue (2019-2024)
6.1.2 Global Drug Delivery Devices Revenue Market Share by Players (2019-2024)
6.2 Global Drug Delivery Devices Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Drug Delivery Devices Head office and Area Served
6.4 Global Drug Delivery Devices Players, Product Type & Application
6.5 Global Drug Delivery Devices Players, Date of Enter into This Industry
6.6 Global Drug Delivery Devices Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Drug Delivery Devices Market Size (2019-2030)
7.2 North America Drug Delivery Devices Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Drug Delivery Devices Market Size by Country (2019-2024)
7.4 North America Drug Delivery Devices Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Drug Delivery Devices Market Size (2019-2030)
8.2 Europe Drug Delivery Devices Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Drug Delivery Devices Market Size by Country (2019-2024)
8.4 Europe Drug Delivery Devices Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Drug Delivery Devices Market Size (2019-2030)
9.2 Asia-Pacific Drug Delivery Devices Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Drug Delivery Devices Market Size by Country (2019-2024)
9.4 Asia-Pacific Drug Delivery Devices Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia
10 LATIN AMERICA
10.1 Latin America Drug Delivery Devices Market Size (2019-2030)
10.2 Latin America Drug Delivery Devices Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Drug Delivery Devices Market Size by Country (2019-2024)
10.4 Latin America Drug Delivery Devices Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Drug Delivery Devices Market Size (2019-2030)
11.2 Middle East & Africa Drug Delivery Devices Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Drug Delivery Devices Market Size by Country (2019-2024)
11.4 Middle East & Africa Drug Delivery Devices Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE
12 PLAYERS PROFILED
12.1 Cipla
12.1.1 Cipla Company Information
12.1.2 Cipla Business Overview
12.1.3 Cipla Revenue in Drug Delivery Devices Business (2019-2024)
12.1.4 Cipla Drug Delivery Devices Product Portfolio
12.1.5 Cipla Recent Developments
12.2 Baxter International
12.2.1 Baxter International Company Information
12.2.2 Baxter International Business Overview
12.2.3 Baxter International Revenue in Drug Delivery Devices Business (2019-2024)
12.2.4 Baxter International Drug Delivery Devices Product Portfolio
12.2.5 Baxter International Recent Developments
12.3 Nipro Corporation
12.3.1 Nipro Corporation Company Information
12.3.2 Nipro Corporation Business Overview
12.3.3 Nipro Corporation Revenue in Drug Delivery Devices Business (2019-2024)
12.3.4 Nipro Corporation Drug Delivery Devices Product Portfolio
12.3.5 Nipro Corporation Recent Developments
12.4 Roche
12.4.1 Roche Company Information
12.4.2 Roche Business Overview
12.4.3 Roche Revenue in Drug Delivery Devices Business (2019-2024)
12.4.4 Roche Drug Delivery Devices Product Portfolio
12.4.5 Roche Recent Developments
12.5 Boehringer Ingelheim
12.5.1 Boehringer Ingelheim Company Information
12.5.2 Boehringer Ingelheim Business Overview
12.5.3 Boehringer Ingelheim Revenue in Drug Delivery Devices Business (2019-2024)
12.5.4 Boehringer Ingelheim Drug Delivery Devices Product Portfolio
12.5.5 Boehringer Ingelheim Recent Developments
12.6 Allergan
12.6.1 Allergan Company Information
12.6.2 Allergan Business Overview
12.6.3 Allergan Revenue in Drug Delivery Devices Business (2019-2024)
12.6.4 Allergan Drug Delivery Devices Product Portfolio
12.6.5 Allergan Recent Developments
12.7 3M
12.7.1 3M Company Information
12.7.2 3M Business Overview
12.7.3 3M Revenue in Drug Delivery Devices Business (2019-2024)
12.7.4 3M Drug Delivery Devices Product Portfolio
12.7.5 3M Recent Developments
12.8 BD
12.8.1 BD Company Information
12.8.2 BD Business Overview
12.8.3 BD Revenue in Drug Delivery Devices Business (2019-2024)
12.8.4 BD Drug Delivery Devices Product Portfolio
12.8.5 BD Recent Developments
12.9 Catalent
12.9.1 Catalent Company Information
12.9.2 Catalent Business Overview
12.9.3 Catalent Revenue in Drug Delivery Devices Business (2019-2024)
12.9.4 Catalent Drug Delivery Devices Product Portfolio
12.9.5 Catalent Recent Developments
12.10 Valeant Pharmaceuticals
12.10.1 Valeant Pharmaceuticals Company Information
12.10.2 Valeant Pharmaceuticals Business Overview
12.10.3 Valeant Pharmaceuticals Revenue in Drug Delivery Devices Business (2019-2024)
12.10.4 Valeant Pharmaceuticals Drug Delivery Devices Product Portfolio
12.10.5 Valeant Pharmaceuticals Recent Developments
12.11 Bayer AG
12.11.1 Bayer AG Company Information
12.11.2 Bayer AG Business Overview
12.11.3 Bayer AG Revenue in Drug Delivery Devices Business (2019-2024)
12.11.4 Bayer AG Drug Delivery Devices Product Portfolio
12.11.5 Bayer AG Recent Developments
12.12 Chiesi
12.12.1 Chiesi Company Information
12.12.2 Chiesi Business Overview
12.12.3 Chiesi Revenue in Drug Delivery Devices Business (2019-2024)
12.12.4 Chiesi Drug Delivery Devices Product Portfolio
12.12.5 Chiesi Recent Developments
12.13 Phillips-Medisize
12.13.1 Phillips-Medisize Company Information
12.13.2 Phillips-Medisize Business Overview
12.13.3 Phillips-Medisize Revenue in Drug Delivery Devices Business (2019-2024)
12.13.4 Phillips-Medisize Drug Delivery Devices Product Portfolio
12.13.5 Phillips-Medisize Recent Developments
12.14 Johnson & Johnson
12.14.1 Johnson & Johnson Company Information
12.14.2 Johnson & Johnson Business Overview
12.14.3 Johnson & Johnson Revenue in Drug Delivery Devices Business (2019-2024)
12.14.4 Johnson & Johnson Drug Delivery Devices Product Portfolio
12.14.5 Johnson & Johnson Recent Developments
12.15 Shandong Weigao
12.15.1 Shandong Weigao Company Information
12.15.2 Shandong Weigao Business Overview
12.15.3 Shandong Weigao Revenue in Drug Delivery Devices Business (2019-2024)
12.15.4 Shandong Weigao Drug Delivery Devices Product Portfolio
12.15.5 Shandong Weigao Recent Developments
12.16 Pfizer
12.16.1 Pfizer Company Information
12.16.2 Pfizer Business Overview
12.16.3 Pfizer Revenue in Drug Delivery Devices Business (2019-2024)
12.16.4 Pfizer Drug Delivery Devices Product Portfolio
12.16.5 Pfizer Recent Developments
12.17 B.Braun
12.17.1 B.Braun Company Information
12.17.2 B.Braun Business Overview
12.17.3 B.Braun Revenue in Drug Delivery Devices Business (2019-2024)
12.17.4 B.Braun Drug Delivery Devices Product Portfolio
12.17.5 B.Braun Recent Developments
12.18 Novartis AG
12.18.1 Novartis AG Company Information
12.18.2 Novartis AG Business Overview
12.18.3 Novartis AG Revenue in Drug Delivery Devices Business (2019-2024)
12.18.4 Novartis AG Drug Delivery Devices Product Portfolio
12.18.5 Novartis AG Recent Developments
12.19 Zhengkang
12.19.1 Zhengkang Company Information
12.19.2 Zhengkang Business Overview
12.19.3 Zhengkang Revenue in Drug Delivery Devices Business (2019-2024)
12.19.4 Zhengkang Drug Delivery Devices Product Portfolio
12.19.5 Zhengkang Recent Developments
12.20 Gerresheimer
12.20.1 Gerresheimer Company Information
12.20.2 Gerresheimer Business Overview
12.20.3 Gerresheimer Revenue in Drug Delivery Devices Business (2019-2024)
12.20.4 Gerresheimer Drug Delivery Devices Product Portfolio
12.20.5 Gerresheimer Recent Developments
12.21 COVIDIEN Medtronic
12.21.1 COVIDIEN Medtronic Company Information
12.21.2 COVIDIEN Medtronic Business Overview
12.21.3 COVIDIEN Medtronic Revenue in Drug Delivery Devices Business (2019-2024)
12.21.4 COVIDIEN Medtronic Drug Delivery Devices Product Portfolio
12.21.5 COVIDIEN Medtronic Recent Developments
12.22 Schott forma vitrum
12.22.1 Schott forma vitrum Company Information
12.22.2 Schott forma vitrum Business Overview
12.22.3 Schott forma vitrum Revenue in Drug Delivery Devices Business (2019-2024)
12.22.4 Schott forma vitrum Drug Delivery Devices Product Portfolio
12.22.5 Schott forma vitrum Recent Developments
12.23 Alkermes
12.23.1 Alkermes Company Information
12.23.2 Alkermes Business Overview
12.23.3 Alkermes Revenue in Drug Delivery Devices Business (2019-2024)
12.23.4 Alkermes Drug Delivery Devices Product Portfolio
12.23.5 Alkermes Recent Developments
12.24 Skyepharma
12.24.1 Skyepharma Company Information
12.24.2 Skyepharma Business Overview
12.24.3 Skyepharma Revenue in Drug Delivery Devices Business (2019-2024)
12.24.4 Skyepharma Drug Delivery Devices Product Portfolio
12.24.5 Skyepharma Recent Developments
13 REPORT CONCLUSION
14 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Drug Delivery Devices by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
2.2.2 Injection Type
2.2.3 Mucosal Type
2.2.4 Implanted Type
2.2.5 Others Type
2.3 Drug Delivery Devices by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 Pharmaceutical Companies
2.3.3 Hospitals
2.3.4 Clinics
2.3.5 Other
2.4 Assumptions and Limitations
3 DRUG DELIVERY DEVICES BREAKDOWN DATA BY TYPE
3.1 Global Drug Delivery Devices Historic Market Size by Type (2019-2024)
3.2 Global Drug Delivery Devices Forecasted Market Size by Type (2025-2030)
4 DRUG DELIVERY DEVICES BREAKDOWN DATA BY APPLICATION
4.1 Global Drug Delivery Devices Historic Market Size by Application (2019-2024)
4.2 Global Drug Delivery Devices Forecasted Market Size by Application (2019-2024)
5 GLOBAL GROWTH TRENDS
5.1 Global Drug Delivery Devices Market Perspective (2019-2030)
5.2 Global Drug Delivery Devices Growth Trends by Region
5.2.1 Global Drug Delivery Devices Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Drug Delivery Devices Historic Market Size by Region (2019-2024)
5.2.3 Drug Delivery Devices Forecasted Market Size by Region (2025-2030)
5.3 Drug Delivery Devices Market Dynamics
5.3.1 Drug Delivery Devices Industry Trends
5.3.2 Drug Delivery Devices Market Drivers
5.3.3 Drug Delivery Devices Market Challenges
5.3.4 Drug Delivery Devices Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Drug Delivery Devices Players by Revenue
6.1.1 Global Top Drug Delivery Devices Players by Revenue (2019-2024)
6.1.2 Global Drug Delivery Devices Revenue Market Share by Players (2019-2024)
6.2 Global Drug Delivery Devices Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Drug Delivery Devices Head office and Area Served
6.4 Global Drug Delivery Devices Players, Product Type & Application
6.5 Global Drug Delivery Devices Players, Date of Enter into This Industry
6.6 Global Drug Delivery Devices Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Drug Delivery Devices Market Size (2019-2030)
7.2 North America Drug Delivery Devices Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Drug Delivery Devices Market Size by Country (2019-2024)
7.4 North America Drug Delivery Devices Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Drug Delivery Devices Market Size (2019-2030)
8.2 Europe Drug Delivery Devices Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Drug Delivery Devices Market Size by Country (2019-2024)
8.4 Europe Drug Delivery Devices Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Drug Delivery Devices Market Size (2019-2030)
9.2 Asia-Pacific Drug Delivery Devices Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Drug Delivery Devices Market Size by Country (2019-2024)
9.4 Asia-Pacific Drug Delivery Devices Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia
10 LATIN AMERICA
10.1 Latin America Drug Delivery Devices Market Size (2019-2030)
10.2 Latin America Drug Delivery Devices Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Drug Delivery Devices Market Size by Country (2019-2024)
10.4 Latin America Drug Delivery Devices Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Drug Delivery Devices Market Size (2019-2030)
11.2 Middle East & Africa Drug Delivery Devices Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Drug Delivery Devices Market Size by Country (2019-2024)
11.4 Middle East & Africa Drug Delivery Devices Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE
12 PLAYERS PROFILED
12.1 Cipla
12.1.1 Cipla Company Information
12.1.2 Cipla Business Overview
12.1.3 Cipla Revenue in Drug Delivery Devices Business (2019-2024)
12.1.4 Cipla Drug Delivery Devices Product Portfolio
12.1.5 Cipla Recent Developments
12.2 Baxter International
12.2.1 Baxter International Company Information
12.2.2 Baxter International Business Overview
12.2.3 Baxter International Revenue in Drug Delivery Devices Business (2019-2024)
12.2.4 Baxter International Drug Delivery Devices Product Portfolio
12.2.5 Baxter International Recent Developments
12.3 Nipro Corporation
12.3.1 Nipro Corporation Company Information
12.3.2 Nipro Corporation Business Overview
12.3.3 Nipro Corporation Revenue in Drug Delivery Devices Business (2019-2024)
12.3.4 Nipro Corporation Drug Delivery Devices Product Portfolio
12.3.5 Nipro Corporation Recent Developments
12.4 Roche
12.4.1 Roche Company Information
12.4.2 Roche Business Overview
12.4.3 Roche Revenue in Drug Delivery Devices Business (2019-2024)
12.4.4 Roche Drug Delivery Devices Product Portfolio
12.4.5 Roche Recent Developments
12.5 Boehringer Ingelheim
12.5.1 Boehringer Ingelheim Company Information
12.5.2 Boehringer Ingelheim Business Overview
12.5.3 Boehringer Ingelheim Revenue in Drug Delivery Devices Business (2019-2024)
12.5.4 Boehringer Ingelheim Drug Delivery Devices Product Portfolio
12.5.5 Boehringer Ingelheim Recent Developments
12.6 Allergan
12.6.1 Allergan Company Information
12.6.2 Allergan Business Overview
12.6.3 Allergan Revenue in Drug Delivery Devices Business (2019-2024)
12.6.4 Allergan Drug Delivery Devices Product Portfolio
12.6.5 Allergan Recent Developments
12.7 3M
12.7.1 3M Company Information
12.7.2 3M Business Overview
12.7.3 3M Revenue in Drug Delivery Devices Business (2019-2024)
12.7.4 3M Drug Delivery Devices Product Portfolio
12.7.5 3M Recent Developments
12.8 BD
12.8.1 BD Company Information
12.8.2 BD Business Overview
12.8.3 BD Revenue in Drug Delivery Devices Business (2019-2024)
12.8.4 BD Drug Delivery Devices Product Portfolio
12.8.5 BD Recent Developments
12.9 Catalent
12.9.1 Catalent Company Information
12.9.2 Catalent Business Overview
12.9.3 Catalent Revenue in Drug Delivery Devices Business (2019-2024)
12.9.4 Catalent Drug Delivery Devices Product Portfolio
12.9.5 Catalent Recent Developments
12.10 Valeant Pharmaceuticals
12.10.1 Valeant Pharmaceuticals Company Information
12.10.2 Valeant Pharmaceuticals Business Overview
12.10.3 Valeant Pharmaceuticals Revenue in Drug Delivery Devices Business (2019-2024)
12.10.4 Valeant Pharmaceuticals Drug Delivery Devices Product Portfolio
12.10.5 Valeant Pharmaceuticals Recent Developments
12.11 Bayer AG
12.11.1 Bayer AG Company Information
12.11.2 Bayer AG Business Overview
12.11.3 Bayer AG Revenue in Drug Delivery Devices Business (2019-2024)
12.11.4 Bayer AG Drug Delivery Devices Product Portfolio
12.11.5 Bayer AG Recent Developments
12.12 Chiesi
12.12.1 Chiesi Company Information
12.12.2 Chiesi Business Overview
12.12.3 Chiesi Revenue in Drug Delivery Devices Business (2019-2024)
12.12.4 Chiesi Drug Delivery Devices Product Portfolio
12.12.5 Chiesi Recent Developments
12.13 Phillips-Medisize
12.13.1 Phillips-Medisize Company Information
12.13.2 Phillips-Medisize Business Overview
12.13.3 Phillips-Medisize Revenue in Drug Delivery Devices Business (2019-2024)
12.13.4 Phillips-Medisize Drug Delivery Devices Product Portfolio
12.13.5 Phillips-Medisize Recent Developments
12.14 Johnson & Johnson
12.14.1 Johnson & Johnson Company Information
12.14.2 Johnson & Johnson Business Overview
12.14.3 Johnson & Johnson Revenue in Drug Delivery Devices Business (2019-2024)
12.14.4 Johnson & Johnson Drug Delivery Devices Product Portfolio
12.14.5 Johnson & Johnson Recent Developments
12.15 Shandong Weigao
12.15.1 Shandong Weigao Company Information
12.15.2 Shandong Weigao Business Overview
12.15.3 Shandong Weigao Revenue in Drug Delivery Devices Business (2019-2024)
12.15.4 Shandong Weigao Drug Delivery Devices Product Portfolio
12.15.5 Shandong Weigao Recent Developments
12.16 Pfizer
12.16.1 Pfizer Company Information
12.16.2 Pfizer Business Overview
12.16.3 Pfizer Revenue in Drug Delivery Devices Business (2019-2024)
12.16.4 Pfizer Drug Delivery Devices Product Portfolio
12.16.5 Pfizer Recent Developments
12.17 B.Braun
12.17.1 B.Braun Company Information
12.17.2 B.Braun Business Overview
12.17.3 B.Braun Revenue in Drug Delivery Devices Business (2019-2024)
12.17.4 B.Braun Drug Delivery Devices Product Portfolio
12.17.5 B.Braun Recent Developments
12.18 Novartis AG
12.18.1 Novartis AG Company Information
12.18.2 Novartis AG Business Overview
12.18.3 Novartis AG Revenue in Drug Delivery Devices Business (2019-2024)
12.18.4 Novartis AG Drug Delivery Devices Product Portfolio
12.18.5 Novartis AG Recent Developments
12.19 Zhengkang
12.19.1 Zhengkang Company Information
12.19.2 Zhengkang Business Overview
12.19.3 Zhengkang Revenue in Drug Delivery Devices Business (2019-2024)
12.19.4 Zhengkang Drug Delivery Devices Product Portfolio
12.19.5 Zhengkang Recent Developments
12.20 Gerresheimer
12.20.1 Gerresheimer Company Information
12.20.2 Gerresheimer Business Overview
12.20.3 Gerresheimer Revenue in Drug Delivery Devices Business (2019-2024)
12.20.4 Gerresheimer Drug Delivery Devices Product Portfolio
12.20.5 Gerresheimer Recent Developments
12.21 COVIDIEN Medtronic
12.21.1 COVIDIEN Medtronic Company Information
12.21.2 COVIDIEN Medtronic Business Overview
12.21.3 COVIDIEN Medtronic Revenue in Drug Delivery Devices Business (2019-2024)
12.21.4 COVIDIEN Medtronic Drug Delivery Devices Product Portfolio
12.21.5 COVIDIEN Medtronic Recent Developments
12.22 Schott forma vitrum
12.22.1 Schott forma vitrum Company Information
12.22.2 Schott forma vitrum Business Overview
12.22.3 Schott forma vitrum Revenue in Drug Delivery Devices Business (2019-2024)
12.22.4 Schott forma vitrum Drug Delivery Devices Product Portfolio
12.22.5 Schott forma vitrum Recent Developments
12.23 Alkermes
12.23.1 Alkermes Company Information
12.23.2 Alkermes Business Overview
12.23.3 Alkermes Revenue in Drug Delivery Devices Business (2019-2024)
12.23.4 Alkermes Drug Delivery Devices Product Portfolio
12.23.5 Alkermes Recent Developments
12.24 Skyepharma
12.24.1 Skyepharma Company Information
12.24.2 Skyepharma Business Overview
12.24.3 Skyepharma Revenue in Drug Delivery Devices Business (2019-2024)
12.24.4 Skyepharma Drug Delivery Devices Product Portfolio
12.24.5 Skyepharma Recent Developments
13 REPORT CONCLUSION
14 DISCLAIMER
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Drug Delivery Devices Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Drug Delivery Devices Revenue Market Share by Type (2018-2023)
Table 7. Global Drug Delivery Devices Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Drug Delivery Devices Revenue Market Share by Type (2024-2029)
Table 9. Global Drug Delivery Devices Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Drug Delivery Devices Revenue Market Share by Application (2018-2023)
Table 11. Global Drug Delivery Devices Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Drug Delivery Devices Revenue Market Share by Application (2024-2029)
Table 13. Global Drug Delivery Devices Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Drug Delivery Devices Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Drug Delivery Devices Market Share by Region (2018-2023)
Table 16. Global Drug Delivery Devices Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Drug Delivery Devices Market Share by Region (2024-2029)
Table 18. Drug Delivery Devices Market Trends
Table 19. Drug Delivery Devices Market Drivers
Table 20. Drug Delivery Devices Market Challenges
Table 21. Drug Delivery Devices Market Restraints
Table 22. Global Top Drug Delivery Devices Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Drug Delivery Devices Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Drug Delivery Devices Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Drug Delivery Devices, Headquarters and Area Served
Table 26. Global Drug Delivery Devices Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Drug Delivery Devices by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Drug Delivery Devices Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Drug Delivery Devices Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Drug Delivery Devices Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Drug Delivery Devices Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Drug Delivery Devices Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Drug Delivery Devices Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Drug Delivery Devices Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Drug Delivery Devices Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Drug Delivery Devices Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Drug Delivery Devices Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Drug Delivery Devices Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Drug Delivery Devices Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Drug Delivery Devices Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Drug Delivery Devices Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Drug Delivery Devices Market Size by Country (2024-2029) & (US$ Million)
Table 45. Cipla Company Detail
Table 46. Cipla Business Overview
Table 47. Cipla Drug Delivery Devices Product
Table 48. Cipla Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 49. Cipla Recent Development
Table 50. Baxter International Company Detail
Table 51. Baxter International Business Overview
Table 52. Baxter International Drug Delivery Devices Product
Table 53. Baxter International Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 54. Baxter International Recent Development
Table 55. Nipro Corporation Company Detail
Table 56. Nipro Corporation Business Overview
Table 57. Nipro Corporation Drug Delivery Devices Product
Table 58. Nipro Corporation Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 59. Nipro Corporation Recent Development
Table 60. Roche Company Detail
Table 61. Roche Business Overview
Table 62. Roche Drug Delivery Devices Product
Table 63. Roche Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 64. Roche Recent Development
Table 65. Boehringer Ingelheim Company Detail
Table 66. Boehringer Ingelheim Business Overview
Table 67. Boehringer Ingelheim Drug Delivery Devices Product
Table 68. Boehringer Ingelheim Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 69. Boehringer Ingelheim Recent Development
Table 70. Allergan Company Detail
Table 71. Allergan Business Overview
Table 72. Allergan Drug Delivery Devices Product
Table 73. Allergan Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 74. Allergan Recent Development
Table 75. 3M Company Detail
Table 76. 3M Business Overview
Table 77. 3M Drug Delivery Devices Product
Table 78. 3M Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 79. 3M Recent Development
Table 80. BD Company Detail
Table 81. BD Business Overview
Table 82. BD Drug Delivery Devices Product
Table 83. BD Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 84. BD Recent Development
Table 85. Catalent Company Detail
Table 86. Catalent Business Overview
Table 87. Catalent Drug Delivery Devices Product
Table 88. Catalent Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 89. Catalent Recent Development
Table 90. Valeant Pharmaceuticals Company Detail
Table 91. Valeant Pharmaceuticals Business Overview
Table 92. Valeant Pharmaceuticals Drug Delivery Devices Product
Table 93. Valeant Pharmaceuticals Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 94. Valeant Pharmaceuticals Recent Development
Table 95. Bayer AG Company Detail
Table 96. Bayer AG Business Overview
Table 97. Bayer AG Drug Delivery DevicesProduct
Table 98. Bayer AG Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 99. Bayer AG Recent Development
Table 100. Chiesi Company Detail
Table 101. Chiesi Business Overview
Table 102. Chiesi Drug Delivery DevicesProduct
Table 103. Chiesi Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 104. Chiesi Recent Development
Table 105. Phillips-Medisize Company Detail
Table 106. Phillips-Medisize Business Overview
Table 107. Phillips-Medisize Drug Delivery DevicesProduct
Table 108. Phillips-Medisize Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 109. Phillips-Medisize Recent Development
Table 110. Johnson & Johnson Company Detail
Table 111. Johnson & Johnson Business Overview
Table 112. Johnson & Johnson Drug Delivery DevicesProduct
Table 113. Johnson & Johnson Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 114. Johnson & Johnson Recent Development
Table 115. Shandong Weigao Company Detail
Table 116. Shandong Weigao Business Overview
Table 117. Shandong Weigao Drug Delivery DevicesProduct
Table 118. Shandong Weigao Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 119. Shandong Weigao Recent Development
Table 120. Pfizer Company Detail
Table 121. Pfizer Business Overview
Table 122. Pfizer Drug Delivery DevicesProduct
Table 123. Pfizer Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 124. Pfizer Recent Development
Table 125. B.Braun Company Detail
Table 126. B.Braun Business Overview
Table 127. B.Braun Drug Delivery DevicesProduct
Table 128. B.Braun Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 129. B.Braun Recent Development
Table 130. Novartis AG Company Detail
Table 131. Novartis AG Business Overview
Table 132. Novartis AG Drug Delivery DevicesProduct
Table 133. Novartis AG Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 134. Novartis AG Recent Development
Table 135. Zhengkang Company Detail
Table 136. Zhengkang Business Overview
Table 137. Zhengkang Drug Delivery DevicesProduct
Table 138. Zhengkang Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 139. Zhengkang Recent Development
Table 140. Gerresheimer Company Detail
Table 141. Gerresheimer Business Overview
Table 142. Gerresheimer Drug Delivery DevicesProduct
Table 143. Gerresheimer Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 144. Gerresheimer Recent Development
Table 145. COVIDIEN Medtronic Company Detail
Table 146. COVIDIEN Medtronic Business Overview
Table 147. COVIDIEN Medtronic Drug Delivery DevicesProduct
Table 148. COVIDIEN Medtronic Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 149. COVIDIEN Medtronic Recent Development
Table 150. Schott forma vitrum Company Detail
Table 151. Schott forma vitrum Business Overview
Table 152. Schott forma vitrum Drug Delivery DevicesProduct
Table 153. Schott forma vitrum Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 154. Schott forma vitrum Recent Development
Table 155. Alkermes Company Detail
Table 156. Alkermes Business Overview
Table 157. Alkermes Drug Delivery DevicesProduct
Table 158. Alkermes Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 159. Alkermes Recent Development
Table 160. Skyepharma Company Detail
Table 161. Skyepharma Business Overview
Table 162. Skyepharma Drug Delivery DevicesProduct
Table 163. Skyepharma Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 164. Skyepharma Recent Development
Table 165. Cipla Company Information
Table 166. Cipla Business Overview
Table 167. Cipla Drug Delivery Devices Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 168. Cipla Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 169. Cipla Recent Development
Table 170. Baxter International Company Information
Table 171. Baxter International Business Overview
Table 172. Baxter International Drug Delivery Devices Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 173. Baxter International Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 174. Baxter International Recent Development
Table 175. Nipro Corporation Company Information
Table 176. Nipro Corporation Business Overview
Table 177. Nipro Corporation Drug Delivery Devices Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 178. Nipro Corporation Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 179. Nipro Corporation Recent Development
Table 180. Roche Company Information
Table 181. Roche Business Overview
Table 182. Roche Drug Delivery Devices Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 183. Roche Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 184. Roche Recent Development
Table 185. Boehringer Ingelheim Company Information
Table 186. Boehringer Ingelheim Business Overview
Table 187. Boehringer Ingelheim Drug Delivery Devices Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 188. Boehringer Ingelheim Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 189. Boehringer Ingelheim Recent Development
Table 190. Allergan Company Information
Table 191. Allergan Business Overview
Table 192. Allergan Drug Delivery Devices Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 193. Allergan Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 194. Allergan Recent Development
Table 195. 3M Company Information
Table 196. 3M Business Overview
Table 197. 3M Drug Delivery Devices Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 198. 3M Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 199. 3M Recent Development
Table 200. BD Company Information
Table 201. BD Business Overview
Table 202. BD Drug Delivery Devices Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 203. BD Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 204. BD Recent Development
Table 205. Catalent Company Information
Table 206. Catalent Business Overview
Table 207. Catalent Drug Delivery Devices Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 208. Catalent Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 209. Catalent Recent Development
Table 210. Valeant Pharmaceuticals Company Information
Table 211. Valeant Pharmaceuticals Business Overview
Table 212. Valeant Pharmaceuticals Drug Delivery Devices Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 213. Valeant Pharmaceuticals Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 214. Valeant Pharmaceuticals Recent Development
Table 215. Bayer AG Company Information
Table 216. Bayer AG Business Overview
Table 217. Bayer AG Drug Delivery DevicesRevenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 218. Bayer AG Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 219. Bayer AG Recent Development
Table 220. Chiesi Company Information
Table 221. Chiesi Business Overview
Table 222. Chiesi Drug Delivery DevicesRevenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 223. Chiesi Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 224. Chiesi Recent Development
Table 225. Phillips-Medisize Company Information
Table 226. Phillips-Medisize Business Overview
Table 227. Phillips-Medisize Drug Delivery DevicesRevenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 228. Phillips-Medisize Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 229. Phillips-Medisize Recent Development
Table 230. Johnson & Johnson Company Information
Table 231. Johnson & Johnson Business Overview
Table 232. Johnson & Johnson Drug Delivery DevicesRevenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 233. Johnson & Johnson Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 234. Johnson & Johnson Recent Development
Table 235. Shandong Weigao Company Information
Table 236. Shandong Weigao Business Overview
Table 237. Shandong Weigao Drug Delivery DevicesRevenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 238. Shandong Weigao Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 239. Shandong Weigao Recent Development
Table 240. Pfizer Company Information
Table 241. Pfizer Business Overview
Table 242. Pfizer Drug Delivery DevicesRevenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 243. Pfizer Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 244. Pfizer Recent Development
Table 245. B.Braun Company Information
Table 246. B.Braun Business Overview
Table 247. B.Braun Drug Delivery DevicesRevenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 248. B.Braun Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 249. B.Braun Recent Development
Table 250. Novartis AG Company Information
Table 251. Novartis AG Business Overview
Table 252. Novartis AG Drug Delivery DevicesRevenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 253. Novartis AG Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 254. Novartis AG Recent Development
Table 255. Zhengkang Company Information
Table 256. Zhengkang Business Overview
Table 257. Zhengkang Drug Delivery DevicesRevenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 258. Zhengkang Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 259. Zhengkang Recent Development
Table 260. Gerresheimer Company Information
Table 261. Gerresheimer Business Overview
Table 262. Gerresheimer Drug Delivery DevicesRevenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 263. Gerresheimer Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 264. Gerresheimer Recent Development
Table 265. COVIDIEN Medtronic Company Information
Table 266. COVIDIEN Medtronic Business Overview
Table 267. COVIDIEN Medtronic Drug Delivery DevicesRevenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 268. COVIDIEN Medtronic Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 269. COVIDIEN Medtronic Recent Development
Table 270. Schott forma vitrum Company Information
Table 271. Schott forma vitrum Business Overview
Table 272. Schott forma vitrum Drug Delivery DevicesRevenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 273. Schott forma vitrum Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 274. Schott forma vitrum Recent Development
Table 275. Alkermes Company Information
Table 276. Alkermes Business Overview
Table 277. Alkermes Drug Delivery DevicesRevenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 278. Alkermes Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 279. Alkermes Recent Development
Table 280. Skyepharma Company Information
Table 281. Skyepharma Business Overview
Table 282. Skyepharma Drug Delivery DevicesRevenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 283. Skyepharma Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 284. Skyepharma Recent Development
Table 285. Authors List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Drug Delivery Devices Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Drug Delivery Devices Revenue Market Share by Type (2018-2023)
Table 7. Global Drug Delivery Devices Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Drug Delivery Devices Revenue Market Share by Type (2024-2029)
Table 9. Global Drug Delivery Devices Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Drug Delivery Devices Revenue Market Share by Application (2018-2023)
Table 11. Global Drug Delivery Devices Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Drug Delivery Devices Revenue Market Share by Application (2024-2029)
Table 13. Global Drug Delivery Devices Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Drug Delivery Devices Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Drug Delivery Devices Market Share by Region (2018-2023)
Table 16. Global Drug Delivery Devices Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Drug Delivery Devices Market Share by Region (2024-2029)
Table 18. Drug Delivery Devices Market Trends
Table 19. Drug Delivery Devices Market Drivers
Table 20. Drug Delivery Devices Market Challenges
Table 21. Drug Delivery Devices Market Restraints
Table 22. Global Top Drug Delivery Devices Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Drug Delivery Devices Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Drug Delivery Devices Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Drug Delivery Devices, Headquarters and Area Served
Table 26. Global Drug Delivery Devices Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Drug Delivery Devices by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Drug Delivery Devices Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Drug Delivery Devices Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Drug Delivery Devices Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Drug Delivery Devices Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Drug Delivery Devices Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Drug Delivery Devices Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Drug Delivery Devices Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Drug Delivery Devices Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Drug Delivery Devices Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Drug Delivery Devices Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Drug Delivery Devices Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Drug Delivery Devices Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Drug Delivery Devices Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Drug Delivery Devices Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Drug Delivery Devices Market Size by Country (2024-2029) & (US$ Million)
Table 45. Cipla Company Detail
Table 46. Cipla Business Overview
Table 47. Cipla Drug Delivery Devices Product
Table 48. Cipla Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 49. Cipla Recent Development
Table 50. Baxter International Company Detail
Table 51. Baxter International Business Overview
Table 52. Baxter International Drug Delivery Devices Product
Table 53. Baxter International Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 54. Baxter International Recent Development
Table 55. Nipro Corporation Company Detail
Table 56. Nipro Corporation Business Overview
Table 57. Nipro Corporation Drug Delivery Devices Product
Table 58. Nipro Corporation Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 59. Nipro Corporation Recent Development
Table 60. Roche Company Detail
Table 61. Roche Business Overview
Table 62. Roche Drug Delivery Devices Product
Table 63. Roche Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 64. Roche Recent Development
Table 65. Boehringer Ingelheim Company Detail
Table 66. Boehringer Ingelheim Business Overview
Table 67. Boehringer Ingelheim Drug Delivery Devices Product
Table 68. Boehringer Ingelheim Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 69. Boehringer Ingelheim Recent Development
Table 70. Allergan Company Detail
Table 71. Allergan Business Overview
Table 72. Allergan Drug Delivery Devices Product
Table 73. Allergan Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 74. Allergan Recent Development
Table 75. 3M Company Detail
Table 76. 3M Business Overview
Table 77. 3M Drug Delivery Devices Product
Table 78. 3M Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 79. 3M Recent Development
Table 80. BD Company Detail
Table 81. BD Business Overview
Table 82. BD Drug Delivery Devices Product
Table 83. BD Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 84. BD Recent Development
Table 85. Catalent Company Detail
Table 86. Catalent Business Overview
Table 87. Catalent Drug Delivery Devices Product
Table 88. Catalent Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 89. Catalent Recent Development
Table 90. Valeant Pharmaceuticals Company Detail
Table 91. Valeant Pharmaceuticals Business Overview
Table 92. Valeant Pharmaceuticals Drug Delivery Devices Product
Table 93. Valeant Pharmaceuticals Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 94. Valeant Pharmaceuticals Recent Development
Table 95. Bayer AG Company Detail
Table 96. Bayer AG Business Overview
Table 97. Bayer AG Drug Delivery DevicesProduct
Table 98. Bayer AG Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 99. Bayer AG Recent Development
Table 100. Chiesi Company Detail
Table 101. Chiesi Business Overview
Table 102. Chiesi Drug Delivery DevicesProduct
Table 103. Chiesi Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 104. Chiesi Recent Development
Table 105. Phillips-Medisize Company Detail
Table 106. Phillips-Medisize Business Overview
Table 107. Phillips-Medisize Drug Delivery DevicesProduct
Table 108. Phillips-Medisize Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 109. Phillips-Medisize Recent Development
Table 110. Johnson & Johnson Company Detail
Table 111. Johnson & Johnson Business Overview
Table 112. Johnson & Johnson Drug Delivery DevicesProduct
Table 113. Johnson & Johnson Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 114. Johnson & Johnson Recent Development
Table 115. Shandong Weigao Company Detail
Table 116. Shandong Weigao Business Overview
Table 117. Shandong Weigao Drug Delivery DevicesProduct
Table 118. Shandong Weigao Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 119. Shandong Weigao Recent Development
Table 120. Pfizer Company Detail
Table 121. Pfizer Business Overview
Table 122. Pfizer Drug Delivery DevicesProduct
Table 123. Pfizer Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 124. Pfizer Recent Development
Table 125. B.Braun Company Detail
Table 126. B.Braun Business Overview
Table 127. B.Braun Drug Delivery DevicesProduct
Table 128. B.Braun Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 129. B.Braun Recent Development
Table 130. Novartis AG Company Detail
Table 131. Novartis AG Business Overview
Table 132. Novartis AG Drug Delivery DevicesProduct
Table 133. Novartis AG Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 134. Novartis AG Recent Development
Table 135. Zhengkang Company Detail
Table 136. Zhengkang Business Overview
Table 137. Zhengkang Drug Delivery DevicesProduct
Table 138. Zhengkang Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 139. Zhengkang Recent Development
Table 140. Gerresheimer Company Detail
Table 141. Gerresheimer Business Overview
Table 142. Gerresheimer Drug Delivery DevicesProduct
Table 143. Gerresheimer Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 144. Gerresheimer Recent Development
Table 145. COVIDIEN Medtronic Company Detail
Table 146. COVIDIEN Medtronic Business Overview
Table 147. COVIDIEN Medtronic Drug Delivery DevicesProduct
Table 148. COVIDIEN Medtronic Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 149. COVIDIEN Medtronic Recent Development
Table 150. Schott forma vitrum Company Detail
Table 151. Schott forma vitrum Business Overview
Table 152. Schott forma vitrum Drug Delivery DevicesProduct
Table 153. Schott forma vitrum Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 154. Schott forma vitrum Recent Development
Table 155. Alkermes Company Detail
Table 156. Alkermes Business Overview
Table 157. Alkermes Drug Delivery DevicesProduct
Table 158. Alkermes Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 159. Alkermes Recent Development
Table 160. Skyepharma Company Detail
Table 161. Skyepharma Business Overview
Table 162. Skyepharma Drug Delivery DevicesProduct
Table 163. Skyepharma Revenue in Drug Delivery Devices Business (2017-2022) & (US$ Million)
Table 164. Skyepharma Recent Development
Table 165. Cipla Company Information
Table 166. Cipla Business Overview
Table 167. Cipla Drug Delivery Devices Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 168. Cipla Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 169. Cipla Recent Development
Table 170. Baxter International Company Information
Table 171. Baxter International Business Overview
Table 172. Baxter International Drug Delivery Devices Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 173. Baxter International Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 174. Baxter International Recent Development
Table 175. Nipro Corporation Company Information
Table 176. Nipro Corporation Business Overview
Table 177. Nipro Corporation Drug Delivery Devices Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 178. Nipro Corporation Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 179. Nipro Corporation Recent Development
Table 180. Roche Company Information
Table 181. Roche Business Overview
Table 182. Roche Drug Delivery Devices Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 183. Roche Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 184. Roche Recent Development
Table 185. Boehringer Ingelheim Company Information
Table 186. Boehringer Ingelheim Business Overview
Table 187. Boehringer Ingelheim Drug Delivery Devices Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 188. Boehringer Ingelheim Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 189. Boehringer Ingelheim Recent Development
Table 190. Allergan Company Information
Table 191. Allergan Business Overview
Table 192. Allergan Drug Delivery Devices Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 193. Allergan Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 194. Allergan Recent Development
Table 195. 3M Company Information
Table 196. 3M Business Overview
Table 197. 3M Drug Delivery Devices Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 198. 3M Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 199. 3M Recent Development
Table 200. BD Company Information
Table 201. BD Business Overview
Table 202. BD Drug Delivery Devices Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 203. BD Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 204. BD Recent Development
Table 205. Catalent Company Information
Table 206. Catalent Business Overview
Table 207. Catalent Drug Delivery Devices Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 208. Catalent Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 209. Catalent Recent Development
Table 210. Valeant Pharmaceuticals Company Information
Table 211. Valeant Pharmaceuticals Business Overview
Table 212. Valeant Pharmaceuticals Drug Delivery Devices Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 213. Valeant Pharmaceuticals Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 214. Valeant Pharmaceuticals Recent Development
Table 215. Bayer AG Company Information
Table 216. Bayer AG Business Overview
Table 217. Bayer AG Drug Delivery DevicesRevenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 218. Bayer AG Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 219. Bayer AG Recent Development
Table 220. Chiesi Company Information
Table 221. Chiesi Business Overview
Table 222. Chiesi Drug Delivery DevicesRevenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 223. Chiesi Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 224. Chiesi Recent Development
Table 225. Phillips-Medisize Company Information
Table 226. Phillips-Medisize Business Overview
Table 227. Phillips-Medisize Drug Delivery DevicesRevenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 228. Phillips-Medisize Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 229. Phillips-Medisize Recent Development
Table 230. Johnson & Johnson Company Information
Table 231. Johnson & Johnson Business Overview
Table 232. Johnson & Johnson Drug Delivery DevicesRevenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 233. Johnson & Johnson Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 234. Johnson & Johnson Recent Development
Table 235. Shandong Weigao Company Information
Table 236. Shandong Weigao Business Overview
Table 237. Shandong Weigao Drug Delivery DevicesRevenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 238. Shandong Weigao Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 239. Shandong Weigao Recent Development
Table 240. Pfizer Company Information
Table 241. Pfizer Business Overview
Table 242. Pfizer Drug Delivery DevicesRevenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 243. Pfizer Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 244. Pfizer Recent Development
Table 245. B.Braun Company Information
Table 246. B.Braun Business Overview
Table 247. B.Braun Drug Delivery DevicesRevenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 248. B.Braun Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 249. B.Braun Recent Development
Table 250. Novartis AG Company Information
Table 251. Novartis AG Business Overview
Table 252. Novartis AG Drug Delivery DevicesRevenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 253. Novartis AG Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 254. Novartis AG Recent Development
Table 255. Zhengkang Company Information
Table 256. Zhengkang Business Overview
Table 257. Zhengkang Drug Delivery DevicesRevenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 258. Zhengkang Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 259. Zhengkang Recent Development
Table 260. Gerresheimer Company Information
Table 261. Gerresheimer Business Overview
Table 262. Gerresheimer Drug Delivery DevicesRevenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 263. Gerresheimer Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 264. Gerresheimer Recent Development
Table 265. COVIDIEN Medtronic Company Information
Table 266. COVIDIEN Medtronic Business Overview
Table 267. COVIDIEN Medtronic Drug Delivery DevicesRevenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 268. COVIDIEN Medtronic Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 269. COVIDIEN Medtronic Recent Development
Table 270. Schott forma vitrum Company Information
Table 271. Schott forma vitrum Business Overview
Table 272. Schott forma vitrum Drug Delivery DevicesRevenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 273. Schott forma vitrum Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 274. Schott forma vitrum Recent Development
Table 275. Alkermes Company Information
Table 276. Alkermes Business Overview
Table 277. Alkermes Drug Delivery DevicesRevenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 278. Alkermes Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 279. Alkermes Recent Development
Table 280. Skyepharma Company Information
Table 281. Skyepharma Business Overview
Table 282. Skyepharma Drug Delivery DevicesRevenue in Drug Delivery Devices Business (2018-2023) & (US$ Million)
Table 283. Skyepharma Revenue in Drug Delivery Devices Business (2018-2023) & (US$ Million) Portfolio
Table 284. Skyepharma Recent Development
Table 285. Authors List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Drug Delivery Devices Product Picture
Figure 5. Global Drug Delivery Devices Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Drug Delivery Devices Market Share by Type: 2022 VS 2029
Figure 7. Injection Type Product Picture
Figure 8. Mucosal Type Product Picture
Figure 9. Implanted Type Product Picture
Figure 10. Others Type Product Picture
Figure 11. Global Drug Delivery Devices Market Size by Application (2023-2029) & (US$ Million)
Figure 12. Global Drug Delivery Devices Market Share by Application: 2022 VS 2029
Figure 13. Pharmaceutical Companies Product Picture
Figure 14. Hospitals Product Picture
Figure 15. Clinics Product Picture
Figure 16. Other Product Picture
Figure 17. Global Drug Delivery Devices Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 18. Global Drug Delivery Devices Market Size, (US$ Million)
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Drug Delivery Devices Product Picture
Figure 5. Global Drug Delivery Devices Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Drug Delivery Devices Market Share by Type: 2022 VS 2029
Figure 7. Injection Type Product Picture
Figure 8. Mucosal Type Product Picture
Figure 9. Implanted Type Product Picture
Figure 10. Others Type Product Picture
Figure 11. Global Drug Delivery Devices Market Size by Application (2023-2029) & (US$ Million)
Figure 12. Global Drug Delivery Devices Market Share by Application: 2022 VS 2029
Figure 13. Pharmaceutical Companies Product Picture
Figure 14. Hospitals Product Picture
Figure 15. Clinics Product Picture
Figure 16. Other Product Picture
Figure 17. Global Drug Delivery Devices Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 18. Global Drug Delivery Devices Market Size, (US$ Million)
